ARCHIVES

Clearinghouse Subgroup asks For Tests On Three Chemicals

This article is from The Cancer Letter archive.

Vol. 03 No. 40 | October 7, 1977

Download PDF Visit The Full Archive

Related Articles

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Monica Bertagnolli To Succeed Schilsky As CALGB Chairman.

November 21, 2008

First Compound From New In Vitro Screening to Enter Clinical Trials

December 5, 1986

Study Confirms Cancer Risk Increase Due To Combined HRT

January 31, 2003

In Brief: D. Gary Gilliland Named President and Director of Fred Hutchinson Cancer Research Center

November 21, 2014

Surgeons Responsible For Improving Their Role, CCIRC Says

July 8, 1977